WHO ICTRP trial
The Effects of Oilgo-Fucoidan on Immune Status, Inflammato-ry Response, and…
TCTR20260126009 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20260126009 |
|---|---|
| Public title | The Effects of Oilgo-Fucoidan on Immune Status, Inflammato-ry Response, and Heavy Metal Concentrations in Patients with Chronic Respiratory Diseases Associated with Air Pollution in Central Taiwan |
| Scientific title | The oligo Fucoidan supplement improve the immune response, inflammatory status, oxidative stress, antioxidant capacity and heavy metal in patients of air pollution related chronic lung inflammation. |
| Primary sponsor | Hi-Q Marine Biotech International Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 0 |
| Countries | Taiwan |
| Conditions | Chronic Respiratory Diseases PM2.5, chronic respiratory diseases, oligo-fucoidan, immune responses, inflammation.;PM2.5, chronic respiratory diseases, oligo-fucoidan, immune responses, inflammation. |
| Interventions | All enrolled participants received conventional therapy for chronic pulmonary diseases and oral supplementation with OF at a dose of 550 mg per tablet, two tablets twice daily, for 12 weeks.;Experimental Dietary Supplement;Oligo-Fucoidan |
| Registration date | Jan 26, 2026 |
| Target size | 60 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: